GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » EBITDA Margin %

Curative Biotechnology (Curative Biotechnology) EBITDA Margin % : 0.00% (As of Mar. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Curative Biotechnology's EBITDA for the three months ended in Mar. 2023 was $-0.65 Mil. Curative Biotechnology's Revenue for the three months ended in Mar. 2023 was $0.00 Mil. Therefore, Curative Biotechnology's EBITDA margin for the quarter that ended in Mar. 2023 was 0.00%.


Curative Biotechnology EBITDA Margin % Historical Data

The historical data trend for Curative Biotechnology's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology EBITDA Margin % Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial - - - - -

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Curative Biotechnology's EBITDA Margin %

For the Biotechnology subindustry, Curative Biotechnology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curative Biotechnology's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curative Biotechnology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Curative Biotechnology's EBITDA Margin % falls into.



Curative Biotechnology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Curative Biotechnology's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-4.427/0
= %

Curative Biotechnology's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-0.653/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biotechnology  (OTCPK:CUBT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Curative Biotechnology EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Curative Biotechnology's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biotechnology (Curative Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.